KILITCH DRUGS (INDIA)
|
KILITCH DRUGS (INDIA) Last 5 Year Financial Ratios History
[Consolidated]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 6.71 | 4.73 | 2.37 | 0.55 | 2.49 |
| CEPS(Rs) | 7.59 | 5.57 | 3.71 | 1.84 | 3.83 |
| DPS(Rs) | - | - | - | - | 0.50 |
| Book NAV/Share(Rs) | 93.85 | 87.43 | 81.82 | 75.85 | 78.11 |
| Tax Rate(%) | 31.06 | 35.37 | 26.43 | 47.61 | 55.40 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 12.70 | 9.19 | 7.74 | -0.01 | 7.30 |
| EBIT Margin(%) | 12.25 | 9.58 | 8.73 | 4.77 | 11.20 |
| Pre Tax Margin(%) | 8.61 | 8.42 | 7.45 | 3.01 | 10.41 |
| PAT Margin (%) | 5.93 | 5.44 | 5.48 | 1.58 | 4.64 |
| Cash Profit Margin (%) | 8.48 | 7.60 | 8.38 | 5.32 | 7.13 |
| Performance Ratios | |||||
| ROA(%) | 3.89 | 3.03 | 2.19 | 0.59 | 2.85 |
| ROE(%) | 5.86 | 4.73 | 3.09 | 0.71 | 3.36 |
| ROCE(%) | 10.26 | 7.26 | 4.40 | 1.95 | 7.59 |
| Asset Turnover(x) | 0.66 | 0.56 | 0.40 | 0.38 | 0.61 |
| Sales/Fixed Asset(x) | 1.27 | 1.28 | 0.97 | 0.76 | 1.20 |
| Working Capital/Sales(x) | 2.43 | 2.55 | 9.74 | 1.58 | 1.84 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.79 | 0.78 | 1.03 | 1.31 | 0.83 |
| Receivable days | 125.11 | 102.77 | 103.03 | 120.72 | 88.79 |
| Inventory Days | 9.21 | 13.72 | 24.29 | 35.14 | 16.62 |
| Payable days | 204.43 | 269.21 | 297.22 | 71.84 | 45.70 |
| Valuation Parameters | |||||
| PER(x) | 20.81 | 35.47 | 34.21 | 148.95 | 79.27 |
| PCE(x) | 18.38 | 30.11 | 21.83 | 44.14 | 51.62 |
| Price/Book(x) | 1.49 | 1.92 | 0.99 | 1.07 | 2.53 |
| Yield(%) | - | - | - | - | 0.25 |
| EV/Net Sales(x) | 1.57 | 2.38 | 1.87 | 2.54 | 3.70 |
| EV/Core EBITDA(x) | 10.64 | 20.26 | 16.02 | 29.75 | 27.03 |
| EV/EBIT(x) | 12.85 | 24.82 | 21.33 | 53.12 | 33.04 |
| EV/CE(x) | 1.01 | 1.30 | 0.63 | 0.95 | 2.14 |
| M Cap / Sales | 1.56 | 2.29 | 1.83 | 2.35 | 3.68 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 22.20 | 66.71 | 28.51 | -35.36 | 61.71 |
| Core EBITDA Growth(%) | 53.96 | 68.00 | 75.65 | -59.73 | 31.67 |
| EBIT Growth(%) | 56.20 | 82.53 | 135.57 | -72.44 | 41.44 |
| PAT Growth(%) | 33.30 | 64.97 | 347.34 | -78.01 | -25.67 |
| EPS Growth(%) | 41.82 | 99.55 | 334.33 | -78.13 | -33.53 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.15 | 0.15 | 0.12 | 0.11 | 0.08 |
| Current Ratio(x) | 1.84 | 1.65 | 1.10 | 2.54 | 3.23 |
| Quick Ratio(x) | 1.81 | 1.57 | 1.05 | 2.29 | 2.99 |
| Interest Cover(x) | 3.36 | 8.22 | 6.84 | 2.71 | 14.25 |
| Total Debt/Mcap(x) | 0.10 | 0.08 | 0.12 | 0.10 | 0.03 |
Compare Financial Ratios of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹565.4 Cr | 10.6% | -5.5% | 154.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹364,015.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
| CIPLA | ₹108,809.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,408.7 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹98,684.0 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹94,213.7 Cr | 5% | 10.4% | 109.1% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | 10.6% |
-5.5% |
154.1% |
| SENSEX | -2.9% |
-0.4% |
20% |
You may also like the below Video Courses
